Evidence map›Paper›PMID 20404927›Full record

ArticlePloS one2010

TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia.

Tobias Strunk, Melanie R Power Coombs, Andrew J Currie, Peter Richmond, Douglas T Golenbock, Liat Stoler-Barak, Leighanne C Gallington, Michael Otto, David Burgner, Ofer Levy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. When the infectious environment meets the AD brain.Molecular neurodegeneration · 2022
    Review
  10. Review
  11. STING Contributes to Host Defense AgainstFrontiers in immunology · 2021
    Article
  12. Review
  13. Article
  14. Vancomycin Is Protective in a Neonatal Mouse Model ofAntimicrobial agents and chemotherapy · 2020
    Article
  15. Article
  16. Frontiers in immunology · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Tobias StrunkSchool of Paediatrics and Child Health, University of Western Australia, Perth, Australia.
Melanie R Power Coombs
Andrew J Currie
Peter Richmond
Douglas T Golenbock
Liat Stoler-Barak
Leighanne C Gallington
Michael Otto
David Burgner
Ofer Levy
University of Western Australia · AUBoston Children's Hospital · USHarvard University · USNational Institutes of Health · USRoyal Children's Hospital · AUUniversity of Massachusetts Chan Medical School · US

Funding

Role of the human microbiota and probioticsZIAAI001080 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI OTTO, MICHAEL · 2009 to 2025
$9.7M
Group B. Streptococci and Toll-like ReceptorsR01AI052455 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2002 to 2012
$4.2M
Adenosine Shapes Neonatal Toll-like Receptor FunctionR01AI067353 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2006 to 2010
$2.1M
CIHRIntramural NIH HHSNIAID NIH HHS R01 AI052455NIAID NIH HHS R01 AI067353NIAID NIH HHS R01 AI067353-01A1
6 · The paper itself

Abstract

backgroundStaphylococcus epidermidis (SE) is a nosocomial pathogen that causes catheter-associated bacteremia in the immunocompromised, including those at the extremes of age, motivating study of host clearance mechanisms. SE-derived soluble components engage TLR2; but additional signaling pathways have also been implicated, and TLR2 can play complex, at times detrimental, roles in host defense against other Staphylococcal spp. The role of TLR2 in responses of primary blood leukocytes to live SE and in clearance of SE bacteremia, the most common clinical manifestation of SE infection, is unknown. METHODOLOGY/PRINCIPAL

findingsWe studied TLR2-mediated recognition of live clinical SE strain 1457 employing TLR2-transfected cells, neutralizing anti-TLR antibodies and TLR2-deficient mice. TLR2 mediated SE-induced cytokine production in human embryonic kidney cells, human whole blood and murine primary macrophages, in part via recognition of a soluble TLR2 agonist. After i.v. challenge with SE, early (1 h) cytokine/chemokine production and subsequent clearance of bacteremia (24-48 h) were markedly impaired in TLR2-deficient mice. CONCLUSIONS/SIGNIFICANCE: TLR2 mediates recognition of live SE and clearance of SE bacteremia in vivo.

Indexed as

AnimalsAntibodiesBacteremiaBloodCells, CulturedCytokinesImmunity, InnateMacrophagesMiceMice, KnockoutSignal TransductionStaphylococcal InfectionsStaphylococcus epidermidisToll-Like Receptor 2AntibodiesCytokinesToll-Like Receptor 2

Identifiers

PMID20404927
PMCPMC2852418
OpenAlexW2136390652

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.